Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine

Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine

  • CN 1,606,435 A
  • Filed: 05/06/2002
  • Published: 04/13/2005
  • Est. Priority Date: 05/08/2001
  • Status: Active Application
First Claim
Patent Images

1. be used to prepare the purposes of anti--parkinsonian medicament based on the transdermal therapeutic system of siloxanes, wherein said transdermal therapeutic system based on siloxanes has 10-40cm 2Area, and contain 0.1-3.15mg/cm 2Sieve for high spit of fland as active component, its sieve that can cause 0.4-2ng/ml after 24 hours in administration is for high spit of fland mean plasma concentration.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×